Tubeimoside-1: A review of its antitumor effects, pharmacokinetics, toxicity, and targeting preparations.

Wang, Chang-Lin; Gao, Ming-Zhou; Gao, Dong-Mei; Guo, Ying-Hui; Gao, Zhan; Gao, Xiang-Ju; Wang, Jie-Qiong; Qiao, Ming-Qi

Wang, Chang-Lin; Gao, Ming-Zhou; Gao, Dong-Mei; Guo, Ying-Hui; Gao, Zhan; Gao, Xiang-Ju; Wang, Jie-Qiong; Qiao, Ming-Qi.

Afiliación

Wang CL; School of Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China.
Gao MZ; Research and Innovation Team of Emotional Diseases and Syndromes in Shandong University of Traditional Chinese Medicine, Jinan, China.
Gao DM; Research and Innovation Team of Emotional Diseases and Syndromes in Shandong University of Traditional Chinese Medicine, Jinan, China.
Guo YH; Institute of Traditional Chinese Medicine Innovation, Shandong University of Traditional Chinese Medicine, Jinan, China.
Gao Z; School of Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China.
Gao XJ; Research and Innovation Team of Emotional Diseases and Syndromes in Shandong University of Traditional Chinese Medicine, Jinan, China.
Wang JQ; School of Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China.
Qiao MQ; Research and Innovation Team of Emotional Diseases and Syndromes in Shandong University of Traditional Chinese Medicine, Jinan, China.

Front Pharmacol ; 13: 941270, 2022.

Article en En | MEDLINE | ID: mdl-35910383

Palabras clave

antitumor; pharmacokinetics; targeting preparations; toxicity; tubeimoside-1

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Front Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: China